AstraZeneca Buys Belgian EsoBiotec for Up to $1 Billion to Boost...

@TheWallStreetJournal Compartió un vínculo

hace un día ·

AstraZeneca Buys Belgian EsoBiotec for Up to $1 Billion to Boost Cell-Therapy Portfolio

www.wsj.com

The deal includes the Belgian biotechs vivo cell-therapy platform, which modifies immune cells within the patients body, potentially increasing access to treatment and reducing costs.

0 Commentarios ·0 Acciones ·26 Views

Please log in to like, share and comment!

Upgrade to Pro

Choose the Plan That's Right for You

Upgrade